Tirzepatide, a recently approved medication, is sparking significant interest in the medical community as a possible treatment for both type 2 diabetes and reducing body fat. This unique drug works by targeting two distinct receptors, GLP-1 and GIP, leading to better glycemic management and significant fat loss in clinical trials . While initial da